RESÚMENES JULIO 2006

.

Basic Neuroscience & Pharmacology

(Haga un click en la información del journal para acceder al resúmen)

 

Genes and Schizophrenia: Beyond Schizophrenia: The Role of DISC1 in Major Mental Illness

William Hennah, Pippa Thomson, Leena Peltonen and David Porteous

Schizophrenia Bulletin 2006 32(3):409-416

 

Schizophrenia in Translation: The Presence of Absence: Habenular Regulation of Dopamine Neurons and the Encoding of Negative Outcomes

Paul D. Shepard, Henry H. Holcomb and James M. Gold

Schizophrenia Bulletin 2006 32(3):417-421

 

Neurobiological Correlates of Violent Behavior Among Persons With Schizophrenia

Kris Naudts and Sheilagh Hodgins

Schizophrenia Bulletin 2006 32(3):562-572

 

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings

Aysegul Yildiz-Yesiloglu and Donna Pauler Ankerst

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 6, 30 August 2006, Pages 969-995

 

Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem

Héctor González-Pardo, Nélida M. Conejo and Jorge L. Arias

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 6, 30 August 2006, Pages 1020-1026

 

Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive–compulsive disorder

Serpil Ersan, Sevtap Bakir, E. Erdal Ersan and Orhan Dogan

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 6, 30 August 2006, Pages 1039-1042

 

Volumetric MRI assessment of brain regions in patients with refractory obsessive–compulsive disorder

Murad Atmaca, Hanefi Yildirim, Huseyin Ozdemir, Ayşe Aydin, Ertan Tezcan and Sinan Ozler

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 6, 30 August 2006, Pages 1051-1057

 

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

Hideaki Mitani, Yukihiko Shirayama, Takeshi Yamada, Kazuhisa Maeda, Charles R. Ashby, Jr. and Ryuzou Kawahara

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 6, 30 August 2006, Pages 1155-1158

 

Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy

Kosuke Narita, Tetsuhito Murata, Tetsuya Takahashi, Hirotaka Kosaka, Naoto Omata and Yuji Wada

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 6, 30 August 2006, Pages 1159-1162

 

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats

Katherine L. Beebe, Thaddeus Block, Charles DeBattista, Christine Blasey and Joseph K. Belanoff

Behavioural Brain Research. Volume 171, Issue 2, 10 August 2006, Pages 225-229

 

Behavioural effects of chronic haloperidol and risperidone treatment in rats

Tim Karl, Liesl Duffy, Elizabeth O’Brien, Izuru Matsumoto and Irina Dedova

Behavioural Brain Research. Volume 171, Issue 2, 10 August 2006, Pages 286-294

 

Olanzapine differentially affects 5-HT2A and 2C receptor mRNA expression in the rat brain

Xu-Feng Huang, Mei Han, Xin Huang, Katerina Zavitsanou and Chao Deng

Behavioural Brain Research. Volume 171, Issue 2, 10 August 2006, Pages 355-362

 

Frontal Signal Hyperintensities in Mania in Old Age

Jose M. de Asis, Blaine S. Greenwald, George S. Alexopoulos, Dimitris N. Kiosses, Manzar Ashtari, Moonseong Heo, and Robert C. Young

Am J Geriatr Psychiatry 14:598-604, July 2006

Modification of Practice-dependent Plasticity in Human Motor Cortex by Neuromodulators

Frank Meintzschel and Ulf Ziemann

Cerebral Cortex 2006 16(8):1106-1115

 

Reflections on the Relationship Between Psychiatric Genetics and Psychiatric Nosology

Kenneth S. Kendler

American Journal of Psychiatry 163:1138-1146, July 2006

A Proton MRSI Study of Brain N-Acetylaspartate Level After 12 Weeks of Citalopram Treatment in Drug-Naive Patients With Obsessive-Compulsive Disorder

Joon Hwan Jang, Jun Soo Kwon, Dong Pyo Jang, Won-Jin Moon, Jong-Min Lee, Tae Hyun Ha, Eun Chul Chung, In Young Kim, and Sun I. Kim

American Journal of Psychiatry 163:1202-1207, July 2006

The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions

Jamie M. Zeitzer, Seiji Nishino and Emmanuel Mignot

Trends in Pharmacological Sciences. Volume 27, Issue 7, July 2006, Pages 368-374

 

Cognitive and Magnetic Resonance Imaging Brain Morphometric Correlates of Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism in Patients With Schizophrenia and Healthy Volunteers

Beng-Choon Ho, Peter Milev, Daniel S. O’Leary, Amy Librant, Nancy C. Andreasen, Thomas H. Wassink

Arch Gen Psychiatry. 2006;63:731-740

 

Reduced Muscarinic Type 2 Receptor Binding in Subjects With Bipolar Disorder

Dara M. Cannon, Richard E. Carson, Allison C. Nugent, William C. Eckelman, Dale O. Kiesewetter, Joan Williams, Denise Rollis, Michele Drevets, Shilpa Gandhi, Gerardo Solorio, Wayne C. Drevets

Arch Gen Psychiatry. 2006;63:741-747

 

 

Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone

Lotta Andréen, Inger Sundström-Poromaa, Marie Bixo, Sigrid Nyberg and Torbjörn Bäckström

Psychopharmacology 2006; Volume 187, Number 2: 209 - 221

 

 

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics

Georg Juckel, Florian Schlagenhauf, Michael Koslowski, Dimitri Filonov, Torsten Wüstenberg, Arno Villringer, Brian Knutson, Thorsten Kienast, Jürgen Gallinat, Jana Wrase and Andreas Heinz 

Psychopharmacology 2006; Volume 187, Number 2: 222 - 228

 

Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders

Norbert Müller and Markus J Schwarz

Expert Review of Neurotherapeutics. July 2006, Vol. 6, No. 7, Pages 1017-1038

 

Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor

Darlene C. Deecher, Chad E. Beyer, Grace Johnston, Jenifer Bray, S. Shah, M. Abou-Gharbia, and Terrance H. Andree

JPET 318:657-665, 2006

 

Time-Dependent Effects of Haloperidol and Ziprasidone on Nerve Growth Factor, Cholinergic Neurons, and Spatial Learning in Rats

Alvin V. Terry, Jr., Vinay Parikh, Debra A. Gearhart, Anilkumar Pillai, Elizabeth Hohnadel, Samantha Warner, Henry A. Nasrallah, and Sahebarao P. Mahadik

JPET 318:709-724, 2006

 

Effect of Vagus Nerve Stimulation on Serotonergic and Noradrenergic Transmission

Adrienne E. Dorr, and Guy Debonnel

JPET 318:890-898, 2006

 

The Genetics of Depression: A Review

Douglas F. Levinson

Biological Psychiatry. Volume 60, Issue 2, 15 July 2006, Pages 84-92

 

Toward Constructing an Endophenotype Strategy for Bipolar Disorders

Gregor Hasler, Wayne C. Drevets, Todd D. Gould, Irving I. Gottesman and Husseini K. Manji

Biological Psychiatry. Volume 60, Issue 2, 15 July 2006, Pages 93-105

 

G72/G30 in Schizophrenia and Bipolar Disorder: Review and Meta-analysis

Sevilla D. Detera-Wadleigh and Francis J. McMahon

Biological Psychiatry. Volume 60, Issue 2, 15 July 2006, Pages 106-114

 

Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test

Fernando T. Consoni, Maria A.B.F. Vital and Roberto Andreatini

European Neuropsychopharmacology. Volume 16, Issue 6, August 2006, Pages 451-458

 

From selective to highly selective SSRIs: A comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram

Shaul Schreiber and Chaim G. Pick

European Neuropsychopharmacology. Volume 16, Issue 6, August 2006, Pages 464-468

 

Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

Boldizsár Czéh, Mária Simon, Barthel Schmelting, Christoph Hiemke and Eberhard Fuchs

Neuropsychopharmacology (2006) 31, 1616–1626

 

Higher 5-HT1A Receptor Binding Potential During a Major Depressive Episode Predicts Poor Treatment Response: Preliminary Data from a Naturalistic Study

Ramin V Parsey, Doreen M Olvet, Maria A Oquendo, Yung-yu Huang, R Todd Ogden and J John Mann

Neuropsychopharmacology (2006) 31, 1745–1749

 

Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis

Aysegul Yildiz-Yesiloglu and Donna Pauler Ankerst

Psychiatry Research: Neuroimaging. Volume 147, Issue 1, 30 June 2006, Pages 1-25

 

Correlations between clinical symptoms, working memory functions and structural brain abnormalities in men with schizophrenia

István Szendi, Marianna Kiss, Mihály Racsmány, Krisztina Boda, Csongor Cimmer, Erika Vörös, Zoltán A. Kovács, György Szekeres, Gabriella Galsi, Csaba Pléh, László Csernay and Zoltán Janka

Psychiatry Research: Neuroimaging. Volume 147, Issue 1, 30 June 2006, Pages 47-55

 

Differentiation of obsessive-compulsive-, panic-, obsessive-compulsive personality-, and non-disordered individuals by variation in the promoter region of the serotonin transporter gene

Marisol Perez, Jessica S. Brown, Suzanne Vrshek-Schallhorn, Frank Johnson and Thomas E. Joiner, Jr

Journal of Anxiety Disorders. Volume 20, Issue 6, 2006, Pages 794-806

 

Toward a biaxial model of “bipolar” affective disorders: Further exploration of genetic, molecular and cellular substrates

Kathleen Askland

Journal of Affective Disorders. Volume 94, Issues 1-3, August 2006, Pages 35-66

 

Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study

S. Bohlhalter, A. Goldfine, S. Matteson, G. Garraux, T. Hanakawa, K. Kansaku, R. Wurzman and M. Hallett

Brain 2006 129(8):2029-2037

 

Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

Noelia V. Weisstaub, Mingming Zhou, Alena Lira, Evelyn Lambe, Javier González-Maeso, Jean-Pierre Hornung, Etienne Sibille, Mark Underwood, Shigeyoshi Itohara, William T. Dauer, Mark S. Ansorge, Emanuela Morelli, J. John Mann, Miklos Toth, George Aghajanian, Stuart C. Sealfon, René Hen, Jay A. Gingrich

Science 28 July 2006: Vol. 313. no. 5786, pp. 536 - 540

Galanin Receptor Antagonists: A Potential Novel Pharmacological Treatment for Mood Disorders

Ogren, Sven Ove; Kuteeva, Eugenia; Hokfelt, Tomas; Kehr, Jan

CNS Drugs. 20(8):633-654, 2006

.

Regresar a RESÚMENES JULIO 2006